Work

Preliminary results demonstrate engraftment with minimal neutropenia with MGTA-456, a CD34expanded cord blood (CB) product in patients transplanted for inherited metabolic disorders (IMD)

Year: 2019

Type: article

Study design: Clinical Trial

Source: Molecular Genetics and Metabolism

DOI: 10.1016/j.ymgme.2018.12.286

Authors: Paul J. Orchard, Glen D. Raffel, Carolyn E.H. Condon, Catherine A. Monaghan, Jennifer A. Braun, Ryan Shanley, Troy C. Lund, Ashish Gupta, Anthony E. Boitano, Michael Cooke, Davis C. Davis, John E. Wagner

Institution: University of Minnesota

Language: English

Topic: Lysosomal Storage Disorders Research

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2914729568

FWCI:

Cites:

Cited by:

Related to: 10